PETER WIRTH
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
JOSE BASELGA, PH.D., JOSE- BASELGA, PH.D., LAWRENCE C. BEST, CASPER BREUM, MARK CHIN, ELISABET DE LOS PINOS, PH.D., JULIE FEDER, PETER FINN, PETER B. FINN, JAVIER GARCIA, SALVADOR GARCIA-ATANCE, LEWIS GEFFEN, GEORGE GOLUMBESKI, PH.D., PEDRO GRANADILLO, JOEL JEAN-MAIRET, PH.D., DAVID JOHNSON, SEBASTIAN JULIA, GIOVANNI MARIGGI, PH.D., EDMUNDO MUNIZ, M.D., PH.D., ART PAPPAS, RAJ PAREKH, PH.D., DALE PFOST, PH.D., ISRAEL RUIZ, CHRISTIAN SCHETTER, KARAN TAKHAR, HENRI TERMEER, ALAN WALTS, ALAN WALTS, PH.D., ALAN E. WALTS, PH.D., MICHAEL WYZGA
DIRECTOR
DIRECTOR
NOUBAR B. AFEYAN, SRINIVAS AKKARAJU, MARK ALLES, STEPHANE BANCEL, JAMES E. BRADNER, CONELY CHEE, DOUGLAS COLE, JORGE CONDE, DEBORAH DUNSIRE, SUE GAIL ECKHARDT, MARSHA FANUCCI, JOSEPH FERRA, JR., JASON HAAS, AMIR NASHAT, ROBERT NELSEN, ANDREW OH, ERIC OLSON, SANJ PATEL, GERALD QUIRK, DAVID ROTH, VICKI SATO, PHILIP SHARP, PHILLIP SHARP, NANCY SIMONIAN, JEREMY SPRINGHORN, KRISTIN STEPHENS, TIMOTHY C. TYSON, HARRY WILCOX III, HARRY W. WILCOX III, RICHARD A. YOUNG
DIRECTOR
SOL BARER, SOL J. BARER, SOL BARER, PH.D., GREGG BELOFF, ISAAC BLECH, KERRIE L. BRADY, JAMES N. CAMPBELL, JAMES N. CAMPBELL, M.D., COLIN HILL, DEZHI KANG, PH.D., JEFFREY B. KINDLER, J. C. LOPEZ, M.D., J.C. LOPEZ, M.D., DANIEL MENDELSON, SARA NAYEEM, ARNOLD ORONSKY, ARNOLD L. ORONSKY, RANDALL M. STEVENS, JOSEPH R. SWEDISH, SHAWN TOMASELLO, MICHAEL J. WARD, STELLA XU, SHENGDA ZAN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-09-16
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-05-24
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-05-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-05-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-12-08
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-01-08
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-01-08

